← Open Payments lookup

BRIAN SMITH: Open Payments

NPI 1790377075 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,116 in 113 payments from 13 companies in 2025. Trend: 2023 $2,833 · 2024 $2,593 · 2025 $2,116

Food & beverage: $2,112Education: $4
CompanyPaymentsAmount
Axsome Therapeutics, Inc.12$431
Supernus Pharmaceuticals, Inc.29$411
E.R. Squibb & Sons, L.L.C.17$299
Otsuka America Pharmaceutical, Inc.10$184
ABBVIE INC.4$177
Alkermes, Inc.10$165
Neurocrine BioSciences, Inc.7$143
Teva Pharmaceuticals USA, Inc.15$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54
Vanda Pharmaceuticals Inc.2$43

Products named: Auvelity, Qelbree, COBENFY, VRAYLAR, ARISTADA, INGREZZA, AUSTEDO XR, ABILIFY ASIMTUFII.

Industry payments across MO — which companies pay providers there.